Serotonin syndrome and the T102-->C polymorphism of the 5-HT2A receptor: a case report.
Lattanzi
L
L
Danesi
R
R
Lastella
M
M
Mungai
F
F
Di Paolo
A
A
Tuccori
M
M
Cassano
G B
GB
Del Tacca
M
M
D000328:Adult; D000483:Alleles; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000235:genetics*; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006720:Homozygote; D006801:Humans; D010624:Phenelzine / Q000009:adverse effects* / Q000627:therapeutic use; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D044402:Receptor, Serotonin, 5-HT2A / Q000235:genetics*; D012008:Recurrence; D012307:Risk Factors; D020230:Serotonin Syndrome / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy
D000928:Antidepressive Agents; D044402:Receptor, Serotonin, 5-HT2A; D010624:Phenelzine